Large-scale hypothesis testing problems, with hundreds or thousands of test statistics "z i " to consider at once, have become familiar in current practice. Applications of popular analysis methods such as false discovery rate techniques do not require independence of the z i 's, but their accuracy can be compromised in high-correlation situations. This paper presents computational and theoretical methods for assessing the size and effect of correlation in large-scale testing. A simple theory leads to the identification of a single omnibus measure of correlation for the z i 's order statistic. The theory relates to the correct choice of a null distribution for simultaneous significance testing, and its effect on inference.
Introduction
Modern computing machinery and improved scientific equipment have combined to revolutionize experimentation in fields such as biology, medicine, genetics, and neuroscience. One effect on statistics has been to vastly magnify the scope of multiple hypothesis testing, now often involving thousands of cases considered simultaneously. The cases themselves are typically of familiar form, each perhaps a simple two-sample comparison, but with their test statistics correlated in some unknown fashion. This paper concerns the effect of correlation on multiple testing procedures, particularly false discovery rate techniques, Benjamini and Hochberg (1995) .
Test statistics from two microarray experiments are displayed in Figure 1 . The experiments, described in Section 2, reported two-sample t-statistics "t i " comparing expression levels under two different conditions for N genes, N = 3226 for the breast cancer study in the left panel, and N = 7680 for the HIV experiment on the right; t i tests the null hypothesis that gene i has the same expression distribution under both conditions. The t i 's have been converted to z-values for easy analysis later, 2, . . . , N, (1.1) where Φ is the standard normal cumulative distribution function (cdf), and G 0 is a putative null cdf for the t-values. G 0 was taken to be a standard student's t cdf with appropriate degrees of freedom for the HIV study, while a permutation method described in Section 4 provided G 0 for the breast cancer experiment (also nearly a student's t cdf.) Assuming G 0 is the correct null distribution for t i , transformation (1.1) yields
for the null cases, called the theoretical null in what follows. Form (1.2) for the null distribution is convenient for general discussion, and can be achieved, or at least approximated, in most testing situations via transformations like (1.1).
Microarray experiments involving genome-wide scans usually presuppose most of the genes to be null, the goal being to identify a small subset of interesting non-null genes for future study, so we expect N (0, 1) to fit the center of the z-value histogram. This is not the case in Figure 1 , where N (0, 1) is too narrow for the breast cancer histogram and too wide for the HIV data.
This paper concerns two related results:
(1) Correlation can cause effects like those seen in Figure 1 , considerably widening or narrowing the distribution of the null z-values.
(2) These effects have substantial impact on simultaneous significance testing, and must be accounted for in deciding which cases should be reported as non-null. The effect of correlation on simultaneous inference is discussed in Section 5, particularly in terms of false discovery rates (FDR). Broadly speaking, a wide central histogram like that for the breast cancer data implies more null z-values in the tails, so that significance levels judged according to the theoretical N (0, 1) null are too liberal. Conversely, the theoretical null is too conservative for the HIV data. This provides some support for the use of an empirical null distribution, a normal curve fit to the central portion of the z-value histogram, Efron (2004 Efron ( , 2006 . The light curves in Figure 1 are empirical nulls, For each of a thousand replications, a standard Benjamini-Hochberg false discovery rate analysis (i.e. based on the theoretical N (0, 1) null distribution) was run at control level q = 0.10, and used to identify a set of "significant" genes. Each of the 1000 points in Figure   2 has coordinates (A, Fdp),
where A is the dispersion variate and Fdp is the true "False discovery proportion", the proportion of identified genes that actually came from the null class.
The overall mean Fdp was 0.096, close to the theoretical control level 0.10, but we see a strong dependence on the dispersion variate A: Fdp averaged 0.34 for the upper 5% of A realizations, and only 0.03 for the lower 5%. The true proportion of false discoveries reported by the "0.10" procedure easily varies by a factor of 10. with an empirical null (1.3) automatically carries out the conditioning process, though in somewhat noisy fashion.
There is a lot at stake here. Table 1 shows the number of gene discoveries identified by the Benjamini-Hochberg two-sided procedure, FDR control level q = 0.10, for the two studies of Figure 1 . The HIV results look much more dramatic using the empirical null distribution N (−0.11, 0.75 2 ). In fact a null standard deviation of σ 0 = 0.75 is quite believable given the amount of correlation, while Figure 1 argues against the theoretical null. The breast cancer data has been used in the microarray literature to compare analysis techniques, under the presumption that better techniques will produce more discoveries, recently for instance in Pawitan et al. (2005) and Storey et al. (2005) . Table 1 suggests caution in this interpretation, where using the empirical null negates any discoveries at all. (Efron (2004) gives reasons other than correlation for distrusting the theoretical null in large-scale testing problems, but only correlation effects will be discussed here.) breast cancer HIV Theoretical Null: 107 22
Empirical Null: 0 180 (1993, 1996) . Permutations and correlated z-values also play a role in Westfall and Young's theory of adjusted p-values (1993), Westfall (1997) , and Ge, Dudoit, and Speed (2003) , but with less direct bearing on the ideas here. A brief discussion and some remarks conclude the paper.
Correlation Effects on the Null Distribution
We begin with a normal-theory analysis for the effects of correlation on the null distribution of z-values. For these calculations it is assumed that all cases are null,
so that the theoretical N (0, 1) null distribution is individually correct. Nevertheless it will turn out that correlation among the z i 's can make the null distribution effectively wider or narrower than N (0, 1), as in Figure 1 . Section 5 shows that in real problems, where we hope to detect some non-null cases, correlation effects can play a major role in their correct identification.
Here is a thumbnail description of the studies featured in Figure 1 , along with some of the notation used in what follows. The breast cancer study compared gene activity in 15 patients observed to have one of two different genetic mutations known to increase breast cancer risk, "BRCA1" or "BRCA2", Hedenfalk et al. (2001) . It included 7 BRCA1 and 8 BRCA2 women, each providing a microarray of expression levels on the same N = 3226
genes. The usual two-sample t-statistic "t i " comparing BRCA2 versus BRCA1 for the 15 gene i expression levels gave z i as in (1.1), with G 0 nearly a student's t-distribution with 13 degrees of freedom, see Section 4. Similarly, the HIV study compared four HIV positive patients versus four HIV negative controls, N = 7680 genes per microarray, van't Wout et al. (2003) . In this case G 0 was taken to be student's t with 6 degrees of freedom. These data sets are discussed further in Efron (2004 Efron ( , 2005 .
Let X represent the full data set, for example an N by n matrix for the breast cancer study, having N = 3226 rows corresponding to genes and n = 15 columns corresponding to microarrays. There each row of X yielded a t statistic t i and then a z-value z i as in 
It is helpful to work with histogram counts rather than with the vector of z-values itself.
Each histogram in Figure 1 has its z-axis partitioned into K = 82 bins of width ∆ = 0.1, running from -4.1 to 4.1. We denote the count vector by y,
y is essentially the order statistic of z, exactly so if we let ∆ → 0. False Discovery Rate methods depend only on the ordered z-values.
The histogram counts y k arise from a partition of Z, the sample space for the z-values, 
and 
Definitions (2.4-2.5) lead to a convenient expression for the covariance matrix of y;
Lemma 1
where C 0 is the multinomial covariance matrix that would apply if the z-values were independent,
and
Here "diag" indicates a diagonal matrix and
(2.12)
Similarly, To approximate δ, we add the assumption of bivariate normality for any pair of z-values,
14)
Letting g(ρ) indicate the empirical density of the N (N − 1) correlations ρ ij , and using (2.6)-(2.14) yields a useful approximation:
Lemma 2 Under the bivariate normal approximation (2.14), the matrix δ in (2.10) has elements
(This compares with Theorem 1 in Owen (2005) ; the assumptions there imply the bivariate normal condition (2.14).)
Application of Lemmas 1 and 2 requires an estimate of the correlation density g(ρ),
which we can obtain from observed correlations between the rows of X. As described in Remark A of Section 7, this gave
for the breast cancer data, and, more roughly,
for the HIV study. It is no accident that g(ρ) has mean near zero; in both cases the data matrix X had its columns standardized to mean zero and variance one (but not quantile normalized), usual practice to negate "brightness" disparities between microarrays, see Bolstad et al. (2003) and . This forces the sum of covariances, and, nearly, the sum of correlations, to be zero. The normality assumed in (2.16) is not crucial, see Remark B.
Section 3 shows that the standard deviation 0.153 is the vital number. Remark E discusses what happens in the absence of standardization.
Approximation (2.16) indicates a substantial amount of global correlation among genes in the breast cancer study, and even more correlation for the HIV study (2.17). The five examples in Owen's (2005) 
for the breast cancer data. The correlation term C 1 in cov(y) = C 0 + C 1 , (2.8), dominates the independence term C 0 . As an informative example we will use later, define 19) these being central and tail counts for a hypothetical null vector z satisfying (2.1). Table 2 shows standard deviations and correlation for Y 0 and Y 1 if the z i 's are independent, or if they are correlated such that cov(y) = C norm . (Table 2 can be computed from cov(y) since Y 0 and Y 1 are linear functions of y). Results for C perm , the permutation estimate from Section 4, agree with C norm . The cutoffs ±1 and 2.5 in (2.19) were chosen for convenient exposition, and could just as well be replaced by similar values, say ±0.75 and 3.0.
We see that gene correlations have a powerful effect on the counts that would be observed under null hypothesis (2.1): standard deviations are multiplied several fold (this being the main point in Owen (2005)), while the negative correlation between the central and tail counts is driven toward -1. Tail null counts play a crucial role in computing false discovery rates, as discussed in Section 5 where the extreme negative correlation between Y 0 and Y 1 is used to "condition" Fdr estimates. Section 3 provides an explanation for the negative correlation.
3. First Eigenvector Lemmas 1 and 2 decompose the covariance matrix of the count vector y into an independence term C 0 and an additional term C 1 that accounts for correlation among the z-values, (2.8). This section presents a simple approximation to C 1 in terms of its first eigenvector, which will be used in Sections 4 and 5 to explain the effects of correlation on simultaneous inference.
The smooth curve in Figure 3 is the first eigenvector of C norm , (2.16)-(2.18) the normaltheory estimate of cov(y) for the breast cancer data, while the jagged curve is the corresponding quantity for the permutation-based estimate C perm of Section 4. The dots indicate the first eigenvector of C norm for the HIV data, using (2.17). All three curves exhibit the same "wing-shaped" form. This will turn out to be proportional to
where ϕ(z) is the standard normal density, (2.6). We use notation (2.3)-(2.6), and work in the discretized framework of Lemmas 1 and 2:
Lemma 3 Suppose g(ρ), the correlation density in (2.15) has mean zero and standard
Then the matrix δ in (2.10) is approximated by the outer product δ= α 2where becomes exact as α → 0, with δ/α 2 →,
Expanding R k (ρ) in a Taylor series around ρ = 0, and ignoring terms of order ρ 3 or higher,
gives
then, since g(ρ) has mean 0, 6) which is (3.3).
Combining the three lemmas yields a useful approximation for the null covariance matrix of the count vector y under the bivariate normal assumptions of Section 2:
Theorem If g(ρ) has mean 0 and standard deviation α, then
Here ν = E{y} as in (2.7), while W has components 8) with w(·) the wing-shaped function (3.1), N the number of cases, and ∆ the bin width.
The Theorem helps explain Figure 2 : the second term in (3.7) dominates cov(y) in our two examples, making its first eigenvector nearly proportional to w(z). 
For the breast cancer value α = 0.153, the proportions are 98% for C 1 , (the crucial quantity for the accuracy of (3.7)), and 45% for C norm = cov(y). N = 3226 in Table 2, Table 3 : Proportion of total variance explained by first eigenvector, as a function of α; for C 1 , the correlation term in (2.8), and also for C norm ; assuming g(ρ) ∼ N (0, α 2 ) and N = 3226.
Proportions for C 1 determine accuracy of approximation (3.7).
The Theorem summarizes the effect of z's entire correlation structure in a single parameter α. This permits a relatively simple analysis of the inferential effects of correlation in what follows. Note: Hsu (1992 Hsu ( , 1996 gives a thorough discussion of "one-factor" ap- for k = 1, 2, . . . , K, while y ∼ (ν, Γ) denotes that vector y has mean ν and covariance Γ.
It is convenient here to consider the number of cases N to be a Poisson variate, say 9) with N 0 = 3226 in the breast cancer study. This slightly simplifies (3.7), to cov(y)= diag(ν) + (αW)(αW) , (3.10)
with ν and W as in (2.7), (3.8) except that N 0 replaces N . If the z-values are independent then (3.9) makes the counts y k independent Poisson variates,
agreeing with (3.10) at α = 0.
A hierarchical model generalizes (3.11) to incorporate dependence. We assume that y depends on a mean vector u, itself random, 12) so that the components of y are conditionally independent given u, but marginally dependent, with mean and covariance
To match (3.10) we need to set Γ = (αW)(αW) , (3.14)
Formulas (3.13)-(3.14) suggest a hierarchical Poisson structure for the count vector y: Figure 3 , so positive A in (3.15) decreases the central counts and increases the tail counts, (2.19), the opposite happening when A is negative. (The "Poisson" column of Table 3 was calculated from model (3.15), α = 0.153 and N = 3226, except that the components of u were truncated at zero.)
Pursuing model (3.15) more carefully, the mean vector u turns out to be roughly proportional to a scaled normal density,
with σ sis. This point is refined in Section 5, where it is shown that "A" can be estimated and used to condition simultaneous hypothesis tests.
Permutation Methods
The previous results depend upon the assumption of bivariate normality for every pair of z-values. Permutation methods lead to a direct empirical estimate "C perm " for cov(y). Carried out here for the breast cancer data, C perm agrees well with the normal-theory estimate C norm , (2.18), and lends support to the inferential theory of Section 5.
Let X represent the 3226×15 matrix of observed expressions. Each row of X, that is each gene, provides a two-sample t-statistic comparing the 8 BRCA2 and 7 BRCA1 expressions, t representing the vector of all 3226 t-values. Repeating the computation after a random permutation of the columns of X, that is after a random division of the patients into groups of 7 and 8, yields permuted matrix X * and t-vector t * . 1000 such permutations were employed to estimate a permutation null distribution G 0 for the t-values (the empirical distribution of all 1000 · 3226 t i 's), which turned out to be slightly shorter-tailed than a standard t variate with 13 degrees of freedom; the z-values for Figure 1 were the calculated as in (1.1), The sample covariance matrix of the 1000 y * 's,
is a nonparametric estimate of the null covariance matrix for y. By permuting entire microarrays we preserve the correlation structure of the genes while nullifying any actual BRCA1-BRCA2 differences. (Note: the matrix X used to form X * in (4.1) had each gene's BRCA1
or BRCA2 average subtracted from its corresponding expression values in order to eliminate any genuine group differences from the permutation results.) Table 2 and Figure 3 demonstrate the similarity of C perm to C norm . for σ 2 0 = 1.2, 1.0, 0.8.
Each permutation vector z

Large-Scale Significance Testing
The scientific world is fond of significance testing because it requires a minimum of probabilistic modeling, no more than the specification of a null hypothesis distribution. However, as described in Sections 2-4, a disturbing danger arises in large-scale testing situations: correlations among the test statistics may substantially widen or narrow the effective null distribution. This section discusses the consequences of correlation effects on false discovery rates and other simultaneous testing techniques, as well as methods for correcting their inferences.
Suppose for a moment that we knew which z i 's among the full set of z-values correspond to null cases. For a given choice of x define
is Y (2.5) in this notation, and T (2.5) = 122 for the breast cancer study. Lehmann and Romano (2005) define the false discovery proportion to be
assuming here that we are searching for "discoveries" only in the right tail. If Fdp(x) were known (but not the identity of the null cases), say Fdp(2.5) = 20/122 = 0.16, the group of 122 genes could be reported as "mostly significant", with the assurance of producing only 16% false discoveries.
In practice Y (x) is unobservable, and likewise Fdp(x). A useful tactic is to replace Y (x)
by its expectation, as in Benjamini and Hochberg (1995) , giving an estimated false discovery rate defined as
Benjamini and Hochberg's procedure actually involves the expected ratio
ingeniously prescribing a data-based choice of x that controls the FDR below some preset value.
Our calculations will focus on Fdr(x), (5.3), an observable ratio that is important and useful in its own right. Fdr(x) is an empirical Bayes estimate of the a posteriori probability that case i is null given z i ≥ x, Storey (2002) , Efron and Tibshirani (2002) , amounting to a version of Storey's "q-value". Since T (x) is observable, Fdr(x) has intuitive interpretation as the expected proportion of null cases among those having z i ≥ x.
Formula (5.3) glosses over the fact that E{Y (x)} itself is not directly calculable. Benjamini and Hochberg's original procedure replaced E{Y (x)} with its upper bound assuming that all N cases were null, as in (2.1) where the theoretical null gives
Improvements on (5.5) are possible via estimation of "p o ", the proportion of null cases, Langaas et al. (2005), Storey et al. (2004) . For p 0 near 1.0, the preferred situation in microarray studies where the goal is to discover a small number of genuinely interesting genes, (5.5) is a good starting point for the discussion of correlation effects.
The hierarchical structure (3.15) gives conditional expectation E{y|A} = ν + AW (5.6) (using only E{y|u} = u, not the full Poisson assumptions). Letting the bin width ∆ → 0 in (2.7) and (3.8) produces a conditional version of (5.6), Remark H,
The term multiplying A equals 4.99 at x = 2.5, giving conditional expectation NΦ(x) · (1.75)
for A = 0.15, and NΦ(x) · (0.25) for A = −0.15.
Even such relatively modest values of A greatly affect the conditional Fdr
Fdr(x|A) = E{Y (x)|A}/T (x), (5.8) which can be expressed as The idea in what follows is that "A" in (5.9), or some equivalent parameter, can be estimated from the central spread of the histogram of z-values, and then used to condition inferences, as in Figure 2 . Generalizing definition (2.19), for x 0 > 0 let
and define
Then (5.6) and definitions (2.7), (3.8) At this point we could substitute A from (5.12) into (5.9) to obtain conditional Fdr 14) where Fdr 0 is the unconditional estimate based on the theoretical null. In situations like that of Figure 2 , the goal would be to accurately assess our position on the A axis in order to better estimate Fdp, rather than estimating the unconditional average of Fdp. This yields misleading inferences at both ends of the Fdp scale. The conditional Fdr estimate correctly tracks Fdp, though with a considerable amount of noise. (Improved forms of (5.14)
that included estimates of p 0 , the null proportion, were used for both the conditional and unconditional Fdr estimates in Figure 5 , based on a version of the locfdr algorithm Efron To reiterate the basic idea, even assuming that null cases individually follow the theoretical null distribution z i ∼ N (0, 1), correlation effects can make the ensemble null distribution behave more like N (0, σ 2 0 ) with σ 0 surprisingly far from 1. Ignoring this effect can undercut any simultaneous testing procedure, not just False Discovery Rates; almost by definition, all hypothesis testing procedures require an accurate notion of "null".
Other factors besides z-value correlations can affect the null distribution. Efron (2004 Efron ( , 2006 suggests two other possibilities that support the use of empirical nulls: unidentified covariates in an observational study, and correlations across microarrays. In fact, Figure 4 makes it seem unlikely that correlation effects alone are responsible for the extreme central overdispersion. These factors, as well as correlation, argue against uncritical use of theoretical null distributions in large-scale testing problems.
Discussion
Massive data sets like those from the breast cancer and HIV studies can be misleadingly comforting in their suggestion of great statistical accuracy. Correlation considerations produce a more sobering picture. A single degree of freedom, embodied by the random variable A in (3.15), can dominate variability as it does in Table 2 . Qui, Klebanov, and Yakovlev (2005) emphasize the harmful effect of correlation, using it as an argument against empirical Bayes microarray analyses such as those in Storey (2002) or Efron et al. (2001) . Their arguments could be used just as well against all other popular microarray analysis techniques.
The results presented in this paper are more optimistic. The correlation effect, though perhaps very large, is shown to manifest itself via the simple wing-shaped function of Section 3. This enables the statistician to identify and remove much of it. In Figure 4 , for example, the tail count Y 1 has standard deviation 15.5, much bigger than the value 4.5 applying to independent z i 's, but the residual standard deviation reduces to 6.5 after prediction from the central counts. This is the idea behind the empirical null, Efron (2004 Efron ( , 2006 , whose most important job is predicting the conditional expectation of the tail null counts.
That being said, Qui et al.'s concern for the consequences of correlation on microarray analyses, nicely summarized in their Section 7, remains pertinent, especially in highcorrelation settings like the HIV study. Improved biomedical methods in exposure, registration, and background control of arrays may alleviate the problem, as might new array designs that incorporate greater gene duplication. Purely statistical improvements can also reduce correlations, for instance by more extensive standardization techniques as in Qui, Brooks, Klebanov, and Yakovlev (2005) . None of this will help, however, if microarray correlations are inherent in the way genes interact at the DNA level, rather than a limitation of current methodology.
Van der Laan and his coauthors, as in van der Laan and Hudson (2005) and Dudoit, van der Laan, and Pollard (2004) , have developed a comprehensive resampling theory for correlated testing problems. This theory is much more general than the one presented here.
However the generality comes at a price in terms of assumptions and applicability: the columns of the N × n data matrix X are considered to be i.i.d. N -vectors, and the main results are justified by asymptotic bootstrap arguments, as the number of microarrays n goes to infinity. Examples like those in Figure 1 , having n N , raise legitimate concerns about the relevance of n → ∞ asymptotics.
Not all large-scale testing situations involve microarrays. Correlation may be less of a problem in other scientific venues like fMRI imaging or time of flight spectroscopy. In any case it seems worthwhile to obtain some overall measure of correlation such as α, (3.2).
Large α's suggest the use of correlation-resistant analysis techniques like the Fdr/empirical null combination. This supports approximation (3.16), which can be improved upon using higher order Edgeworth terms.
E (Section 3)
The vectors ν and W in (3.15) relate to the zero th and second Hermite polynomials. Standardization of the columns of X suppresses the first polynomial, with important consequences here. Without standardization, the first eigenvector of cov(y), divided by ϕ(z), may be proportional to z, the first polynomial, instead of the second polynomial z 2 − 1.
F (Section 4)
The permutation calculations at the beginning of Section 4 provided 1000 z * i values for each index i, after which the empirical distribution of all 3226×1000 values provided the "permutation null" G 0 . This kind of calculation can ignore correlation among the z i 's since it only depends on marginal permutation distributions. It is worth restating that permutation null distributions as typically computed tend to resemble theoretical nulls, and do not automatically compensate for correlation effects. The sophisticated permutation algorithms of Westfall and Young (1993) and Westfall (1997) do involve gene-wise correlations, but applied toward different purposes than in this paper. Their "step-down max-T" algorithm gave results similar to using a N (0, 1) null for the breast cancer and HIV studies.
G (Section 4) Permutation methods produced unstable results for the HIV data.
Partly this reflects small sample sizes, with only 34 distinct permutations available. Of more concern, there seem to be secular effects systematically disturbing expression levels across microarrays. A version of Remark A based on random subsamples of the 7680 genes gave (2.17). estimates, as in (7.8), are both convenient and appropriate for the calculations here.
H (Section
